Interneuron Development Is Disrupted in Preterm Brains With Diffuse White Matter Injury: Observations in Mouse and Human by Stolp, H B et al.
Frontiers in Physiology | www.frontiersin.org 1 July 2019 | Volume 10 | Article 955
ORIGINAL RESEARCH
published: 30 July 2019
doi: 10.3389/fphys.2019.00955
Edited by: 
Justin Dean, 
The University of Auckland, 
New Zealand
Reviewed by: 
Rachel Anne Hill, 
Monash University, 
Australia
Alistair Jan Gunn, 
The University of Auckland, 
New Zealand
*Correspondence: 
Helen B. Stolp 
hstolp@rvc.ac.uk
†Present address: 
Yoko Arai, 
 BrainEver, Paris, France 
Specialty section: 
This article was submitted to 
Embryonic and Developmental 
Physiology, 
a section of the journal 
Frontiers in Physiology
Received: 25 January 2019
Accepted: 09 July 2019
Published: 30 July 2019
Citation:
Stolp HB, Fleiss B, Arai Y, 
Supramaniam V, Vontell R, Birtles S, 
Yates AG, Baburamani AA, 
Thornton C, Rutherford M, 
Edwards AD and Gressens P  
(2019) Interneuron Development Is 
Disrupted in Preterm Brains With 
Diffuse White Matter Injury: 
Observations in 
Mouse and Human.
Front. Physiol. 10:955.
doi: 10.3389/fphys.2019.00955
Interneuron Development Is 
Disrupted in Preterm Brains With 
Diffuse White Matter Injury: 
Observations in Mouse and Human
Helen B. Stolp1,2*, Bobbi Fleiss2,3,4, Yoko Arai3†, Veena Supramaniam2, Regina Vontell2,5, 
Sebastian Birtles2, Abi G. Yates2,6, Ana A. Baburamani2, Claire Thornton1,2, 
Mary Rutherford2, A. David Edwards2 and Pierre Gressens2,3
1 Department for Comparative Biomedical Sciences, Royal Veterinary College, London, United Kingdom, 2 Department of 
Perinatal Imaging & Health, Centre for the Developing Brain, School of Biomedical Engineering and Imaging Science, King’s 
College London, London, United Kingdom, 3 Université de Paris, NeuroDiderot, Inserm, Paris, France, 4 School of Health and 
Biomedical Sciences, RMIT University, Melbourne, VIC, Australia, 5 Department of Neurology, University of Miami, Miller 
School of Medicine, Miami, FL, United States, 6 Department of Pharmacology, University of Oxford, Oxford, United Kingdom
Preterm brain injury, occurring in approximately 30% of infants born <32 weeks gestational 
age, is associated with an increased risk of neurodevelopmental disorders, such as autism 
spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). The 
mechanism of gray matter injury in preterm born children is unclear and likely to 
be multifactorial; however, inflammation, a high predictor of poor outcome in preterm 
infants, has been associated with disrupted interneuron maturation in a number of animal 
models. Interneurons are important for regulating normal brain development, and disruption 
in interneuron development, and the downstream effects of this, has been implicated in 
the etiology of neurodevelopmental disorders. Here, we utilize postmortem tissue from 
human preterm cases with or without diffuse white matter injury (WMI; PMA range: 23+2 
to 28+1 for non-WMI group, 26+6 to 30+0 for WMI group, p = 0.002) and a model of 
inflammation-induced preterm diffuse white matter injury (i.p. IL-1β, b.d., 10 μg/kg/injection 
in male CD1 mice from P1–5). Data from human preterm infants show deficits in interneuron 
numbers in the cortex and delayed growth of neuronal arbors at this early stage of 
development. In the mouse, significant reduction in the number of parvalbumin-positive 
interneurons was observed from postnatal day (P) 10. This decrease in parvalbumin neuron 
number was largely rectified by P40, though there was a significantly smaller number of 
parvalbumin positive cells associated with perineuronal nets in the upper cortical layers. 
Together, these data suggest that inflammation in the preterm brain may be a contributor 
to injury of specific interneuron in the cortical gray matter. This may represent a potential 
target for postnatal therapy to reduce the incidence and/or severity of neurodevelopmental 
disorders in preterm infants.
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INTRODUCTION
While preterm birth has a multifactorial etiology, it is widely 
recognized as being precipitated by pro-inflammatory events 
(reviewed by Hagberg et  al., 2015), and these vulnerable 
infants are at risk of further exposure to inflammation and 
infection. As such, in preterm born infants, the severity and 
duration of inflammation highly correlates with long-term 
outcome (Kuban et  al., 2015). Inflammation is also a risk 
factor in the development of neurodevelopmental disorders 
(Hagberg et  al., 2012; Jiang et  al., 2018), such as autism 
spectrum disorder (ASD), attention deficit hyperactivity 
disorder (ADHD), childhood epilepsy and disorders of learning, 
and cognition and emotional development. Given the 
associations, it is possibly unsurprising that up to 30% of 
preterm born infants are diagnosed with a neurodevelopmental 
disorders in childhood (Marlow et  al., 2005; Wood et  al., 
2005; Johnson et  al., 2010; Franz et  al., 2018). 
Neurodevelopmental disorders have a substantial effect on 
the quality of life of affected individuals and their families, 
but we  have limited options to improve the brain health of 
these infants. The development of therapies is hampered by 
the fact that the neuropathology of developmental disorders 
is as mixed as the diagnosis, varying both between and within 
specific clusters of disorders.
Specifically in preterm born infants, patterns of white 
matter injury, and increasingly of a gray matter injury, are 
recognized and associated with poor outcome. In contemporary 
cohorts of preterm infants, white matter injury includes 
periventricular leukomalacia in the most severe cases and 
more commonly diffuse white matter injury (Counsell et  al., 
2003; Back et  al., 2007; Buser et  al., 2010). The scale of 
white matter injury correlates with the severity of the outcome 
for preterm born infants (Counsell et al., 2008; Keunen et al., 
2017; Tusor et  al., 2017). Diffuse white matter injury has 
been successfully modeled in mice and sheep by recapitulating 
the exposure to early-life inflammation seen in preterm born 
infants (Mallard et  al., 2003; Stolp et  al., 2005; Dean et  al., 
2009; Favrais et al., 2011), though chronic hypoxia can result 
in similar pathology (Back et  al., 2006), supporting a 
multifactorial etiology. Improvements in imaging modalities 
have made it possible to study the ultrastructure of the gray 
matter. Concomitantly, there has been a reduction in the 
most severe forms of white matter injury allowing the nature 
of subtle gray matter deficits to be  probed in more detail. 
The microstructural pathology in the gray matter of preterm 
infants is still an on-going study (Ajayi-Obe et  al., 2000; 
Boardman et  al., 2006; Ball et  al., 2013; Batalle et  al., 2019), 
but it is clearly linked with the later development of cognitive 
disorders (Kersbergen et al., 2016; Lean et al., 2017). However, 
inflammation, synaptic dysfunction, and altered gamma-
aminobutyric acid (GABA) signaling are frequently identified 
as underlying causes and mechanisms of injury in 
neurodevelopmental disorders (Pardo and Eberhart, 2007; 
Pinto et  al., 2010; Deidda et  al., 2014; Coelewij and Curtis, 
2018; Dark et al., 2018). This suggests that synaptic dysfunction 
and altered GABA signaling are valid candidates to mediate 
the neurodevelopmental disorders associated with 
encephalopathy of prematurity.
Interneurons make up approximately 20–30% of cells 
within the cortex (slightly higher in primates than mice; 
Jones, 2009) and provide inhibitory balance for the excitatory 
pyramidal neurons by connecting cortical layers and cortical 
regions via interactions with glia, the vasculature, and other 
neurons (Cossart, 2011; Marin, 2012, 2013; Barber et  al., 
2018). Interneurons are primarily born within the medial 
and lateral ganglionic eminence during embryonic 
development and migrate to the cortex during the early 
postnatal period, where they mature over the first few weeks 
of life in mice (Cossart, 2011), equivalent to early childhood 
in humans. This maturation process includes differential 
expression of subtype markers (see below), maturation of 
dendritic arbors, and synpases, as well as changes in synaptic 
activity, and contacts, and transient networks (Butt et  al., 
2005, 2017; Cossart, 2011; Marques-Smith et  al., 2016). 
There is a complex array of interneuron subtypes based 
on their morphological, electrophysiological, and molecular 
signatures (Kelsom and Lu, 2013). Major populations of 
interneurons in the cortex include those immunopositive 
for somatostatin (SST), calbindin (CalB), calretinin (CalR), 
and parvalbumin (PV). Changes in interneurons are termed 
an interneuronopathy, and deficits in each of these cellular 
subtypes have been associated with neurodevelopmental 
disorders (Marin, 2012), including those prevalent in preterm 
born children. There is currently little known about the 
effect of prematurity on cortical interneurons, although a 
recent study by Panda et  al. (2018) has shown a general 
decrease in GABAergic (glutamate decarboxylase, GAD, 
positive) interneurons in the cortex, primarily driven by 
a decrease in parvalbumin-positive interneurons in the 
upper (layers II–IV), and to a lesser degree, lower (layers 
V and VI) cortex (Panda et  al., 2018). However, this study 
focused on the effect of early or later prematurity and did 
not specifically study cases of encephalopathy of prematurity 
compared with controls. Changes in parvalbumin-positive 
interneurons in particular are commonly reported in studies 
of patients with neurodevelopmental disorders or in associated 
animal models (Kataoka et  al., 2010; Gandal et  al., 2012; 
Bitanihirwe and Woo, 2014; Barnes et al., 2015; Filice et al., 
2016; Hashemi et  al., 2018; Vogt et  al., 2018). Parvalbumin 
knockout mice have ASD-like behavioral symptoms (Wohr 
et al., 2015). Additionally, knockout of metabotropic glutamate 
receptors (mGluR5) in parvalbumin interneurons results 
in specific memory deficits, altered sensory motor gating, 
and increased compulsive-like behaviors (Barnes et  al., 
2015). Similarly, maternal immune activation, a common 
experimental model for ASD, reduces parvalbumin inhibitory 
activity on pyramidal neurons, resulting in defects in 
attentional shifting (Canetta et  al., 2016). Interneurons, 
including parvalbumin-positive interneurons, have a 
specialized area of extracellular matrix (chondroitin sulfate 
proteoglycans) surrounding them, called a perineuronal net. 
It has been shown in the past years that this net forms 
and enlarges during development, representing a marker 
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of a functionally mature neuron. The perineuronal net plays 
a role in regulating plasticity, and deficits are associated 
with epilepsy induced plasticity (Galtrey and Fawcett, 2007).
Here, we  aim to assess whether there is a subtype specific 
disruption in interneuron maturation in our population of 
preterm infants with diffuse white matter injury compared 
with age-matched controls. Further to this, in mice exposed 
to IL-1β-induced inflammation, which produces diffuse white 
matter injury (Favrais et  al., 2011; Krishnan et  al., 2017), 
we  will assess the long-term trajectory of interneuron 
development and the consequences for wider cortical 
maturation.
MATERIALS AND METHODS
Human Postmortem Tissue
Written informed parental consent was acquired according 
to the National Health Services (NHS) UK guidelines and 
study ethics were obtained from the National Research Ethics 
Services (West London), UK (ethics number: 07/H0707/139; 
Postmortem Magnetic Imaging Study of the Developing Brain). 
Thirteen extremely preterm postmortem brains (<30  weeks 
gestational age, 1 female/12 male) of vaginally delivered 
neonates were used in this study and obtained from the 
Perinatal Pathology Department, Imperial Health Care Trust, 
London, UK. The primary cause of death for each case was 
assessed by a pathologist. Brain tissue blocks from these 
cases had a postmenstrual age (PMA) range from 23+2 to 
30+0 weeks, calculated by GA (at birth), plus age at death 
(PMA range for each cohort: 23+2 to 28+1 for non-WMI cases, 
26+6 to 30+0 for WMI cases, p  =  0.002). The details of each 
case are summarized in Table 1. Amniotic fluid infections 
were identified in most cases; however, no cases had identifiable 
vascular thrombosis or leptomeningitis. From postmortem 
examination, brains were assessed macroscopically and 
microscopically. Seven cases showed no significant brain 
pathology, these were used as non-neuropathologic controls 
(no WMI cases). Six brains had evidence of diffuse (non-cystic) 
white matter injury (WMI cases) including white matter 
gliosis and focal lesions.
As previously reported (Supramaniam et  al., 2013; Vontell 
et  al., 2013) after postmortem, whole brains were fixed with 
4% formalin for 5–7  weeks, depending on size. The whole 
brains were sliced by a pathologist, and tissue blocks were 
processed on a Bright Tissue Processor (Bright Instrument 
Co. Ltd.). Paraffin-embedded tissue blocks of the frontal lobe 
at the level of the caudate (i.e., anterior to Ammon’s Horn) 
were sectioned at 6  μm using a Leica RM2245 microtome 
(Leica Microsystems Ltd.).
Animal Model
All animal procedures were approved by the UK Home 
Office according to the regulations in the Animal (Scientific 
Procedures) Act (2012), and the King’s College London 
(KCL) Animal Welfare and Ethical Review Board (AWERB; 
TABLE 1 | Summary of clinical information of human postmortem cases.
Group Sex GA at birth (weeks) Postnatal age PMA at death (weeks) Clinical context Neuropathology
 No white matter injury
1 M 23 + 2 5 min 23 + 2 Ass IUGR, oligohydramnios, congestive 
heart failure
2 M 23 + 6 9 h 51 min 23 + 6 Ass IUGR (twin) Leptomeninges congested with focal 
hemorrhages
3 F 24 + 1 4 h 40 min 24 + 1 Extreme prematurity, congestive heart 
failure
4 M 24 + 2 IUD/stillbirth 24 + 2 Constricted umbilical cord, congestive 
heart failure
5 M 25 + 3 21 h 7 min 25 + 3 Ass IUGR (twin) Odematous brain with transtentorial 
herniation of the unci
7 M 26 + 2 43 h 26 + 3 TTT, Ass IUGR, pulmonary hemorrhage
8 M 28 + 1 <1 h 28 + 1 Oligohydramnios, lung hypoplasia, 
congestive heart failure
 Non-cystic white matter injury
1 M 26 + 5 1 days 7 h 
52 min
26 + 6 Ass IUGR, oligohydramnios, congestive 
heart failure
PVWM injury/pathology in PVWM at 
angles of the lateral ventricle
2 M 24 + 6 16 days 19 h 
10 min
27 + 0 AAAFI, PPROM, acute necrotizing 
pneumonia
PVWM injury/pathology in PVWM at 
angles of the lateral ventricle
3 M 24 + 0 5 weeks 1 day 
8 h 25 min
29 + 1 AAAFI, retroplacental hemorrhage PVWM injury/pathology in PVWM at 
angles of the lateral ventricle
4 M 29 + 3 11 h 17 min 29 + 3 TTT, AAAFI, hydrops fetalis GM/IVH
5 M 27 + 5 12 days 29 + 4 Ass IUGR, necrotizing entercolitis, uterine 
constraint/oligohydramnios
PVWM injury/pathology in PVWM at 
angles of the lateral ventricle
6 M 26 + 0 1 min 30 + 0 Necrotizing enterocilitis Patchy WM gliosis
Ass IUGR, asymmetric interauterine growth restriction; AAAFI, acute ascending amniotic fluid infectin; GM, germinal matrix; IVH, intraventricular hemorrhage; PPROM, preterm 
premature rupture of the membranes; PVMW, periventricular white matter; TTT, twin-twin transfusion; WM, white matter.
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PPL 70/8376). Inflammation-associated brain injury of the 
preterm born infant was modeled in mice by exposing them 
to systemic inflammation from postnatal day 1 (P1) through 
to P5; P0 is the day of birth, as previously reported (Favrais 
et al., 2011). P1–P5 is approximately equivalent to the period 
of 23–32 weeks gestation for brain development in the human 
pregnancy, based on a mixture of myelination and cortical 
development processes (Clancy et  al., 2001, 2007; Semple 
et  al., 2013). Pregnant CD-1 mice were purchased from 
Charles Rivers and transferred to the KCL Biological Services 
Unit (BSU) at embryonic day (E) 16 of pregnancy. Animals 
were housed separately in individually ventilated cages with 
food and water available ad libitum, in a temperature controlled 
environment with a 12  h light-dark cycle. This injection 
paradigm only produces consistent and reproducible diffuse 
white matter injury in male mice (Favrais et  al., 2011), 
compared with female mice. Therefore, following birth, female 
pups were culled by cervical dislocation, and male pups 
were randomly divided into litters for saline or IL-1β treatment 
(typically numbering four to seven pups per “new” litter). 
Each pup received a 5 μl intraperitoneal (i.p.) injection twice 
daily from P1 to P4 and a final injection in the morning 
at P5 (Favrais et al., 2011). IL-1β (R&D Systems) was diluted 
in saline to a working concentration of 8  ng/μl (for a final 
dose of 10  μg/kg/injection). Animals remained housed in 
litter groups until weaning (P21), when they were group 
housed (3–4/cage). At P5 (6  h post final injection), P10 
(approximate time of six layered cortex formation), P40 
(when interneuron markers are mature), and P60 (early 
adulthood) randomly selected pups from each litter were 
killed by terminal anesthesia (i.p. pentobarbitone overdose) 
and perfused with saline followed by cold 4% 
paraformaldehyde. The brain was dissected out of the skull 
and immersion fixed in Bouin’s solution (Sigma). Fixed tissue 
was washed and dehydrated through graded alcohol 
(progressing from 50 to 100%) and embedded in paraffin 
wax (Sigma, UK). Coronal 6-μm thick consecutive sections 
were cut and placed on microscope slides, with three sections 
at an interval of approximately 250  μm per slide.
Immunohistochemistry and Microscopy
As previously reported (Vontell et  al., 2013), postmortem 
human sections underwent routine paraffin removal and 
rehydration, then were placed in 3% hydrogen peroxide to 
quench endogenous peroxidase activity, and immersed in 
preheated 10  mM citric acid with 0.1% Tween-20 (VWR 
International Ltd.) for 30 min and cooled at room temperature 
for 20  min. Sections were blocked with 5% normal goat or 
horse serum (as appropriate, based on the secondary antibody 
host species) and primary antibodies were incubated overnight 
at 4°C; concentrations below. The next day, biotinylated 
secondary antibodies (1:200, Vector Laboratories) goat anti-
rabbit, goat anti-rat, or horse anti-mouse were incubated for 
1  h at room temperature, then with avidin-biotin complex 
(ABC, 1:200, Vector Laboratories, UK) for 1  h. The reactions 
were visualized with 3,3′-diamino-benzidine (DAB; Sigma-
Aldrich Company) for 10 min. Sections were then dehydrated, 
cleared in xylene, and cover-slipped. Primary antibodies used 
to identify all neurons in the developing human cortex were 
mouse anti-HuC/HuD (1:500, Life Technologies) and 
interneuron markers; mouse anti-calretinin (CalR; 1:100, 
Millipore), mouse anti-calbindin D-28 (CalB; 1:100, Sigma), 
rabbit anti-parvalbumin (PV; 1:500, Abcam), rat anti-
somatostatin (SST; 1:50, Abcam), rabbit polyclonal 
neuropeptide Y (NPY; 1:5,000, Abcam). Routine H&E staining 
was also performed on this cohort of brain samples to assess 
for gross neuropathologies.
Mouse tissue was processed as described above and stained 
as previously reported (Stolp et  al., 2011). Mouse anti-CTIP2 
(1:400; Abcam) was used to identify neurons in the developing 
cortical plate in the mouse (Stolp et  al., 2011; Garcez et  al., 
2018). Interneuron populations were stained with one of rabbit 
anti-Parvalbumin (PV, 1:200, Abcam), rabbit anti-Calretinin 
(CalR, 1:200, Swant), rat anti-Somatostatin (SST, 1:100, Abcam), 
rabbit anti-Neuropeptide Y (NPY, 1:100, Abcam), mouse anti-
Calbindin (CalB, 1:100, Sigma), mouse anti-Reelin (1:500, 
Calbiochem), rabbit anti-Vasoactive Intestinal Peptide (VIP, 
1:100, Abcam). Perineuronal nets were identified using 
biotinylated Wisteria floribunda Lectin (WFL, 1:200, Vector). 
Sections were incubated in the appropriate biotinylated or 
fluorescently-tagged secondary antibody: biotinylated goat anti-
rabbit or mouse (1:200, Vector); donkey anti-mouse-488; donkey 
anti-rabbit-488/546 (1:400, Invitrogen) or streptavidin-488 (1:400, 
Invitrogen). All antibodies and lectins were diluted in 1% 
donkey serum in phosphate-buffered saline with 1% Tween-20. 
Sections with fluorescent secondaries were incubated with DAPI 
for 5  min (4′,6-diamidino-2-phenylindole, 1:1,000, Sigma-
Aldrich) and mounted with ProlongGold (Thermo 
Fisher Scientific).
A subset of brains were processed for Golgi staining using 
the FD Rapid GolgiStain Kit (FD Neurotechnologies Inc.), 
following the manufacturer’s instructions. Briefly, brain tissue 
was washed in dH2O immediately following collection and 
then incubated in impregnation solution for 2  weeks. After 
this period, the samples were incubated in Solution C for 
3  days before tissue sections were cut with a Vibratome 
(Leica) at 100 μm thickness, mounted in slides, and dehydrated 
through ethanol and xylene before mounting with DPX 
(Sigma).
Image Analysis and Statistics
Human tissue sections were visualized with bright-field 
microscopy, using a light microscope (Leica DM6000B, Leica 
Microsystems Ltd.), CCD color video camera (Leica CTR6000, 
Leica, UK), equipped with a motorized stage for automated 
sampling (MicroBrightfield Inc.). Cell number was assessed 
using optical fractionator stereological software (Stereo 
Investigator v8.27, MicroBrightfield Inc.). Contours were drawn 
around the frontal cortex magnified by a 5× objective 
(0.0426  mm2), with an average area for each contour of 
1 mm2. Counting was performed at the magnification provided 
by the 40× objective, from multiple counting sites throughout 
the contour, to allow unbiased sampling of the frontal cortex 
and an estimate of cell density. The number of counting 
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sites was varied for each cell type, due to differences in 
density (determined from preliminary assessments of cell 
number); overall, an average of 35–45 counting sites were 
used for each contour (Vontell et  al., 2013, 2015). Three 
contours were assessed for each brain region of interest 
(cortex and subcortical white matter, therefore, approx. 3 mm2 
assessed in total for each) and averaged to produce the 
estimated cell density for each region. Neurite lengths were 
assessed in positively stained somatostatin and neuropeptide 
Y neurons from images obtained with a ×40 objective. An 
average of seven cells were assessed per case, using ImageJ 
software (Schneider et  al., 2012).
Mouse tissue sections were imaged with a Leica SP5 confocal 
microscope (P5, P10, and P40 fluorescently stained mouse 
tissue) or Leica DM4000 upright microscope (P40 mouse 
tissue). For cell counts, upper (II–IV) and lower (V and VI) 
layers were delineated as a region of interest for each image, 
and the immunoreactive cells counted manually, by a blinded 
observer, using the ImageJ cell counter tool. For the 
parvalbumin/perineuronal net counts, multiple markers were 
used so that single- and double-labeled neurons could 
be  counted together in a single region of interest. Images 
were taken from the area of the somatosensory cortex identified 
by the presence of the barrel cortex, and measurements were 
averaged from both the medial (M1) and lateral (S1BF) cortex 
(Paxinos and Franklin, 2012), from three sections per brain. 
Therefore, data were averaged from three to six images per 
brain (tissue was excluded if it was damaged or where the 
staining had excessively high background or was non-specific), 
and from three to six brains per treatment and age (P5: 
n  =  3–6 both groups; P10: n  =  5 saline, n  =  6 IL-1β; P40: 
n  =  3 saline, n  =  5 IL-1β).
Cell counts are presented as mean  ±  standard deviation 
(SD). Statistical analysis was performed using Prism 7 
(GraphPad). Postmortem human samples were analyzed with 
an unpaired t-test. Grouped data from P5 tissue were analyzed 
using a two-way ANOVA for treatment and cell population, 
with post hoc analysis performed with Sidak’s multiple 
comparison test. For P10 and P40 data, grouped data from 
each cell population were analyzed using a two-way ANOVA 
for treatment and layer, with post hoc analysis performed 
with Sidak’s multiple comparison test. A p <0.05 was considered 
statistically significant.
Golgi stained neurons, with consistent stain impregnation 
and isolation from neighboring stained cells, were imaged with 
a Leica DM6000B microscope for analysis. Stacked images in 
the z-axis were obtained at ×40 magnification, with a 1  μm 
interval. Dendritic branching and intersections were quantified 
and analyzed by Sholl analysis (Gutierrez and Davies, 2007), 
using ImageJ image processing program. Image stacks were 
compressed in one 2D image, and the center of the soma was 
marked for reference. Concentric circles, with radii increasing 
by 9.06  μm (50 pixels) per circle, were set from the soma 
center. Multiple neurons (10–15 from multiple slices across 
the brain) were analyzed from three brains per treatment, and 
results are presented as the average number (± SD) of dendritic 
intersections per concentric circle, for each treatment group. 
Sholl profiles were statistically compared using a two-way 
ANOVA for treatment and distance from soma.
For spine analysis, dendrites were isolated in images of 
neuronal cells collected for Sholl analysis. Dendrites chosen 
were of different lengths, with a substantial portion in the 
plane of focus, and were representative of spine density and 
morphology of unselected dendrites. Spine density of selected 
dendrites was analyzed using Image-Pro Premier image 
analysis software (MediaCybernectics). Data were blinded, 
and images were categorized as having a high or low synaptic 
frequency (41 from saline treated brains, 57 from IL-1β 
treated) based on the number of synaptic protrusions along 
the length of the dendrite, and the spaces, if any, between 
the protrusions (Smrt and Zhao, 2010; Phillips and Pozzo-
Miller, 2015). This categorical data were statistically compared 
using the Fisher exact test, with a p <0.05 considered 
statistically significant.
RESULTS
Preterm Born Infants With Diffuse White 
Matter Injury Had Reduced Number of 
Calretinin Interneurons in the Cortex and 
Altered Arborization of Other Interneuron 
Populations
Stereological assessment of cell number in the frontal cortex 
of the developing human brain showed no change in the total 
number of neurons, identified by HuC/HuD immunoreactivity, 
with 53,104  ±  11,009 immunopositive cells/mm2 found in the 
control brains (n  =  5), and 52,120  ±  6,327 cells/mm2 in the 
cortex of the white matter injury cases (n  =  4). In contrast, 
there was a significant decrease in the cortical calretinin-
immunopositive cells in the white matter injury cases, compared 
with preterm infants without white matter injury (from 
1,084 ± 96 to 663 ± 327 cells/mm2, p = 0.043, Figures 1A–D). 
Calbindin- and parvalbumin-positive cells were observed in 
low numbers in both cases, insufficient for determining statistical 
significant changes. Somatostatin and neuropeptide Y 
immunopositive interneurons also occurred much less frequently 
than calretinin positive cells and were not found in the cortex 
at this stage of development. However, the cells immunopositive 
for these markers were found in the subcortical white matter, 
and these were analyzed for neurite length and branching. 
There were no statistical differences in the number of cells in 
either interneuron (SST or NPY) subpopulation between preterm 
infants with or without white matter injury (n  =  5 for both). 
The branching of immunopositive cells was assessed with a 
modified Sholl Analysis, and there was a significant decrease 
in the arborization of neurons in both of these interneuron 
classes. Somatostatin cells in white matter injury cases had 
shorter leading neurite length (33.2 ± 8.7 μm, n = 6, compared 
with 56.7  ±  8.5  μm in the no WMI cases, n  =  6; p  <  0.001) 
and fewer branches (7.4  ±  1.4 compared with 4.6  ±  0.7, 
p  =  0.001). Neuropeptide Y immunopositive neurons also had 
shorter neurites (51.5 ± 5.2 μm compared with 72.6 ± 13.7 μm 
in no-WMI group, n  =  5–6; p  =  0.01) and fewer branches 
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(5.3  ±  0.85 WMI, compared with 8.1  ±  1.9, p  =  0.009) in 
white matter injury cases (Figures 1E,F).
The Developmental Trajectory of a Number 
of Interneuron Populations Is Disturbed in 
a Mouse Model of Preterm Birth
In mice with IL-1β-induced inflammation, at the end of the 
inflammatory exposure (P5), there was no gross alteration in 
the cortical layering (Figure 2A, DAPI) or cell density. In 
addition, no statistically significant change in CTIP2 
immunoreactive neuron number per cortical area was observed 
(saline: 204.3  ±  37.4 cells, IL-1β: 162.7  ±  29.8 cells, p  <  0.086, 
Figure 2B), suggesting no overall change in the development 
of the early cortical neurons with injury. There was a significant 
decrease in the number of reelin-positive (saline: 64.2  ±  5.1 
cells, IL-1β: 51.7  ±  5.7 cells, p  =  0.047) and calretinin-positive 
(saline: 55.7  ±  9.7 cells, IL-1β: 31.3  ±  12.6 cells, p  <  0.001) 
neurons in the IL-1β treated animals compared with the 
saline-treated control (Figure 2C). In comparison to these 
reelin- and calretinin-positive cells, other interneuron populations 
were present in a much lower number (Figures 2A,C), as 
would be  expected at this early stage of brain development, 
as the majority of interneuron markers do not fully develop 
until the second or third postnatal week in the mouse (Cossart, 
2011). In general, at this stage of development, the interneuron 
populations were present in higher numbers in the lower 
cortical layers (layer V and VI) than in the upper layers (II, 
III, and IV). Specific analysis of interneuron populations (PV, 
CalB, SST, and NPY) in the upper layers showed no difference 
between treatment groups (Figure 2D). In the lower layers, 
two-way ANOVA analysis showed a significant treatment effect 
(p < 0.043), reflecting a general increase in the same interneuron 
populations in the IL-1β group (Figure 2E). However, no 
significant difference was found for individual populations 
following correction for multiple comparisons.
At P10 (Figure 3), the somatostatin, neuropeptide Y, 
calretinin, and calbindin populations were present in greater, 
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FIGURE 1 | Interneuron development in the cortex and subcortical white matter of the damaged preterm brain is altered compared with age-matched cases 
without white matter injury. Cell counts were performed in cortical and subcortical white matter in the frontal lobe, anterior to Ammon’s Horn. Total cortical neuronal 
number was assessed counting HuC/HuD positive neurons (A,C). A significant decrease in Calretinin (CalR)-positive interneurons was observed in the cortex of 
preterm brains with non-cystic white matter injury (WMI) compared with no WMI controls (B,D). No significant difference in Somatostatin (SST) or Neuropeptide Y 
(NPY)-positive interneurons was observed in the subcortical white matter. However, SST and NPY labeled interneurons from non-cystic white matter injury showed 
shorter neurites, with fewer branches (E,F). Data presented as mean ± SD; scale bar = 100 μm (A–D), 25 μm (E,F); *p < 0.05, **p < 0.01, ***p < 0.001; SST, 
somatostatin; NPY, neuropeptide Y; WMI, white matter injury.
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FIGURE 2 | P5 mice with inflammation-induced brain damage also show altered interneuron development across the cortex. Cortical development was 
assessed based on immunohistochemistry for general microstructure (DAPI), developing cortical neurons (CTIP2) and interneuron subpopulations at P5 (A,B). 
A significant decrease in Reelin and Calretinin (CalR)-positive neurons was observed in the whole cortex (C), but no change in CTIP2 positive 
pyramidal neurons (B). Assessment of the less prevalent interneuron populations according to upper (II–IV) or lower (V, VI) cortical layer distribution showed a 
small but significant increase the majority of interneuron populations in the lower layers (treatment effect, p = 0.04, two-way ANOVA) and no significant change 
in the upper layers (D,E). Data presented as mean ± SD; scale bar = 100 μm. *p < 0.05, ***p < 0.001. CalR, calretinin; PV, parvalbumin; SST, somatostatin; 
NPY, Neuropeptide Y; CalB, calbindin.
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though still relatively low, numbers, and there was no 
significant difference in their presence, or distribution through 
the cortex between the saline and IL-1β treated groups. 
Parvalbumin-positive cells were found in significantly greater 
numbers in layer IV, V, and VI (p  =  0.005). There was an 
overall decrease in the number of parvalbumin-positive 
neurons (p  <  0.014), with no significant layer effect 
(Figure 3B).
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FIGURE 3 | Developmental pattern of interneuron injury changes by P10 in mice with inflammation-induced brain damage. Interneuron populations were  
assessed again at P10 by immunohistochemistry (A) and quantified (B–E) for number and distribution through cortical layers. There was a significant decrease in 
the number of parvalbumin (PV)-positive interneurons across the cortex (B; treatment effect, p = 0.01, two-way ANOVA), but no change for somatostatin (SST), 
neuropeptide Y (NPY), calretinin (CalR), or calbindin (CalB, C–F). Data presented as mean ± SD; scale bar = 100 μm. *p < 0.05.
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FIGURE 4 | Long-term changes in parvalbumin-positive interneurons and their perineuronal nets extend to P40 in mice with inflammation-induced brain damage. 
The beginning of perineuronal net formation could be seen in the cortex, primarily in layer IV, from as early as P10 (A, top row). The aggregation of the perineuronal 
nets and their association with the parvalbumin-positive interneurons became more pronounced through development (A, lower rows). In the IL-1β challenged mice, 
there was no gross alteration in perineuronal net formation or in the number of cortical parvalbumin neurons (B). However, there was a significant decrease in the 
number of PV+/PNN+ neurons in the upper layers of the cortex (C). Data presented as mean ± SD; scale bar = 100 μm. *p < 0.05. PV, parvalbumin); PNN, 
perineuronal nets.
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Parvalbumin Interneurons Show Long-
Term Disruption in Neuronal Number, 
Arborization, and Association With 
Perineuronal Nets
To determine whether perturbations in parvalbumin number 
present at P10  in mice following IL-1β-induced inflammation 
persisted beyond this early developing period, the number of 
these neurons was assessed at a later stage of development. 
At P40, there was a trend toward a decrease in parvalbumin 
cells in the upper layers of the cortex but not the lower layers 
(Figures 4A,B). The maturation state of parvalbumin interneurons 
was assessed by the presence of perineuronal nets, which start 
to form in a loose association with the parvalbumin neurons 
in the barrel cortex from P10  in the mouse (Figure 4A). 
Clear association of the nets with parvalbumin-positive 
interneurons is visible by P40, which mature further as 
development continues (P60; Figure 4A; Ueno et  al., 2017). 
When explored in more detail, a statistically significant decrease 
in parvalbumin-positive neurons that had fully formed 
perineuronal nets (17.6  ±  0.2 cells/mm2 in saline, 15.1  ±  0.5 
cells/mm2 in IL-1β, p  =  0.008) was seen specifically in the 
upper layer of the IL-1β treated animals (Figure 4C). At this 
age, there was a relatively high proportion of parvalbumin 
neurons without perineuronal nets (25% in saline), but there 
was no change in this subpopulation of neurons with treatment 
(32% in IL-1β group, p  =  0.8, Figure 4C). Likewise, in brains 
from both saline and IL-1β treated animals, a small number 
of perineuronal nets were observed without PV staining 
(1.5  ±  0.3 cells/mm2 in saline and 1.2  ±  0.2 cells/mm2 in 
IL-1β), but the proportions were very low and there was no 
significant difference between groups. In comparison with these 
small but significant changes in parvalbumin interneurons, 
there remained no significant difference in the number of either 
neuropeptide Y, calretinin, or VIP-positive neurons in the cortex 
between saline-and IL-1β-treated animals (Figures 5A–C).
Long-Term Changes in Arborization and 
Spine Density Are Broadly Observed in 
Areas of the Cortex With Disrupted 
Parvalbumin Interneuron Development
Golgi staining was performed to visualize the individual neurons 
within the cortex, to allow Sholl and spine analysis to 
be  performed. No significant effect of IL-1β treatment was 
observed on the overall dendritic morphology of neurons at 
P40 (Figure 5D), but there was a statistically significant shift 
in the number of dendrites showing a low frequency of spines, 
with 35% of the spines from Golgi stained cells from IL-1β 
treated animals showing a low spine frequency compared with 
15% in saline-treated tissue (p  =  0.007, Figures 5E,F).
DISCUSSION
We have revealed a general decrease in the number of GABAergic 
interneurons in the cortex of preterm born human infants 
with diffuse white matter injury, compared with age-matched 
controls, and similarly in mice with diffuse white matter injury 
following IL-1β-induced inflammation. This interneuron deficit 
(reduced numbers and reduced morphological complexity) 
occurred in the absence of severe injury, as there were no 
changes in the numbers of neurons in the cortex in the clinical 
(human) or preclinical (mouse) study. Also, subtypes of 
interneurons were differentially affected over development 
indicating population specific vulnerabilities. The early disruption 
of interneuron populations in our clinical sample is supported 
by our preclinical evidence that not only did these changes 
persist but were found together with changes in the excitatory-
inhibitory cell balance, spine density, and the density of 
perineuronal nets. Altogether, these data support the hypothesis 
that inflammation associated with preterm birth may alter the 
excitatory-inhibitory balance in the brain. This effect would 
partly explain the link between exposure to inflammation during 
development and poor neurodevelopmental outcomes in these 
infants that lead to life-long functional impairment. However, 
Canetta et al. (2016) have shown that maternal immune activation 
at the very beginning of neurogenesis (E9  in the mouse) can 
also result in parvalbumin-specific pathology, possibly suggesting 
a particular susceptibility of this cell population to disturbances 
in normal development. More work will be required to explore 
this concept.
Interneurons are produced within the medial ganglionic 
eminence throughout development and migrate to all cortical 
layers (Butt et  al., 2005, 2017). Interneuron fate is genetically 
coded and follows a clear pattern of migration and maturation, 
related to the regulatory transcription factors imposed in the 
ganglionic eminence at the time of cell production (reviewed 
by Marin, 2012; Kelsom and Lu, 2013). It is postulated that 
the developmental period during which an injury or perturbation 
occurs will influence the cell population affected. Injury would 
also interact with genetic risks, which may affect when phenotypes 
caused by altered genetic code manifest, explaining the variety 
of neurodevelopmental disorders associated with similar 
phenotypes. Animal models allow the progression of injury 
to be assessed, in comparison with the snapshot of information 
typically obtained from clinical studies. The utility of the mice 
with IL-1β-induced inflammation and subsequent diffusion 
white matter injury used here is that the injury is broadly 
comparable in nature to that seen in our patient samples. 
Specifically, this model displays the hallmarks of injury observed 
in contemporary preterm born infants: hypomyelination, 
axonopathy, oligodendrocyte dysmaturation and also, reported 
here and previously, no gross cortical injury evidenced by no 
change in cortical neuronal number (Favrais et al., 2011; Schang 
et  al., 2014; Krishnan et  al., 2017; Rangon et  al., 2018). In 
this model, females have a less severe and more transient 
phenotype, which is why they were not used in this study 
(unpublished data), suggesting a bias seen in the animal model 
similar to that observed in the human population (Marlow 
et al., 2005). However, it is of course impossible to recapitulate 
the complex processes leading to injury in the human completely 
with any model, and we would acknowledge that the differences 
in the magnitude of the observed changes probably lie in 
multifactorial injury to the infants.
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In this animal model, at the time when the brain is still 
being subjected to an inflammatory challenge (Krishnan et al., 
2017), interneurons appear slightly increased in the cortex 
of injured animals compared with controls. It is worth noting 
that most interneuron populations are not properly established 
in the cortex at this stage (Cossart, 2011), reflected in lower 
numbers than were found in the adult analysis. As development 
progresses, and after the injurious stimuli has resolved (at 
P10, Krishnan et  al., 2017), a mild parvalbumin-specific 
neuronal reduction becomes apparent. Parvalbumin 
interneurons make up approximately 40% of GABAergic 
cortical interneurons, which, compared with the less frequent 
interneuron subpopulations, may make the detection of 
statistical changes in the cell population easier. Parvalbumin 
interneurons are fast-spiking interneurons with basket or 
chandelier morphology that make synaptic connections on 
proximal dendrites and the soma of target neurons (reviewed 
by Marin, 2012; Kelsom and Lu, 2013). The cells produce 
oscillations in the gamma range (30–80 Hz), which is associated 
with cognitive processes such as memory and attention 
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FIGURE 5 | By P40 the majority of interneuron pathology has recovered, but there are long-term changes in dendritic spines associated with the early 
inflammation-induced brain damage. No difference was seen in the number of neuropeptide Y (NPY), calretinin (CalR), or VIP-positive neurons (A–C) at P40. Golgi 
staining was performed to assess the general morphological development of cortical neurons at this stage. (E) Image (a) is an example of a well stained cortical 
neuron used for spine analysis and images (b,c) are representative images of spine density on dendrites in the brains of IL-1β and saline treated mice, respectively. 
There was no significant difference in the dendritic arborisation (D) but there was a significant reduction in spine frequency on the dendritic processes in the IL-1β 
challenged mice (E,F). Data presented as mean ± SD; scale bar = 60 μm for Ea, 10 μm for Eb,c. **p < 0.01.
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(Bartos et  al., 2007; Canetta et  al., 2016). This function may 
partly explain why parvalbumin knockout mice have an 
ASD-like phenotype: repetitive behaviors, impaired social 
interaction and communication, as well as reduced startle 
response and increased risk of seizure (Wohr et  al., 2015).
The severity of injury will also have an effect on outcome, 
with more severe injury producing larger, more widespread 
changes. Previous studies of gray matter injury have been 
performed in human preterm infants with cystic white matter 
injury, in which there is extensive cell death and reactive 
gliosis. However, in our human post-mortem cases of diffuse 
white matter injury, there was no overall change to neuronal 
number. Possibly unsurprisingly then, compared with our data 
of limited and cell type-specific changes, studies of gray matter 
injury in severe cystic cases show more widespread gray matter 
injury (Andiman et  al., 2010; Kinney et  al., 2012). As such, 
our data are an important contribution to understanding how 
interneuron deficits may impact on neurodevelopmental 
disorders for contemporaneous cohorts of preterm born infants. 
The diffuse white matter injury studied here is the predominant 
form of injury seen in preterm born infants, and cystic cases 
account for only approximately 5% of neuropathology, based 
on MRI and ultrasound imaging studies in preterm cohorts 
(Hamrick et  al., 2004; reviewed by Back, 2017).
It must be noted that preterm birth occurs due to a complex, 
and often undetermined etiology and can be concomitant with 
other clinical findings, e.g., intrauterine growth restriction 
(IUGR), which in themselves are also predictive of reduced 
brain development (Rees et  al., 2008; O’Shea et  al., 2009; 
Korzeniewski et  al., 2017). The fact that many infants in our 
cases (both WMI and non-WMI groups) have IUGR may well 
be  a confounder in the injury observed. While the mouse 
data clearly links interneuron (and white matter) pathology 
with inflammation, it is likely that there are many contributing 
factors in preterm brain injury, of which inflammation is 
only one. This, and the different developmental timetables of 
mouse and human brains, may also explain the different 
interneuronopathies identified in this study. Adding to that 
complexity is the varying age range between the preterm white 
matter injury and non-white matter injury cohorts examined 
in this study. From a developmental point of view, the greater 
PMA of WMI group compared with control should be associated 
with more visible interneurons in the cortex (through processes 
of migration and maturation). As a result, we  suggest that the 
significant decrease in interneuron numbers in this group is, 
if anything, an underestimate of the interneuron injury in 
preterms with diffuse WMI. However, the longer survival times 
of these infants does increase the difficulty of defining the 
etiology of the interneuron injury, as many features of the ex 
utero environment may contribute to the injury severity. For 
instance, Panda et  al. (2018) suggest that deficits in maternal 
estrogen is a major contributor to interneuron injury. That 
being said, in the data from the mouse model, when exposure 
to maternal estrogen (and other factors of the external 
environment) is constant, there is still a reduction in interneurons.
The significant early decreases seen for interneurons in 
general in this study are similar to findings recently reported 
by Panda et  al. (2018), where early prematurity in humans 
was associated with a reduction in parvalbumin-positive 
interneurons, primarily in the upper cortical layers, and an 
increase in somatostatin-positive interneurons also in the upper 
cortex. There was also an overall decrease in glutamate 
decarboxylase (GAD)-positive neurons, attributed primarily to 
the changes in the parvalbumin subpopulation. However, a 
direct comparison with Panda and colleagues is difficult as 
their cases were compared based on the degree of prematurity 
rather than on their diagnosis (Panda et al., 2018). This resulted 
in a comparison of early born infants that had long survival 
times (up to 3–4  weeks) with later born preterm infants who 
had survival times of only 2–3  days. The role of postnatal 
care in interneuron development has been shown in a model 
of preterm delivery in the baboon, where 14  days of positive 
pressure ventilation lead a reduction in the numbers of calretinin-
positive cells in the visual cortex (Verney et al., 2010). Although 
this and other confounding factors are almost impossible to 
remove from a human postmortem study, we  are confident 
that our cases provide evidence more specifically related to 
the effects of prematurity on interneuron development without 
the specific effect of postnatal care.
To further assess interneuron number, we  investigated their 
migration through the subcortical white matter in our clinical 
cases. Reduced morphological complexity was observed for 
somatostatin and neuropeptide Y immunopositive neurons 
within the subcortical white matter in this study. As these 
neurons are still migrating, changes in their morphology may 
reflect a disruption in migration that will contribute to later 
reduced interneurons in the cortex, another process associated 
with neurodevelopmental disorders (Marin, 2013). It is possible 
that a delay in migration could explain initial reductions in 
interneuron number in the cortex that lessen or normalize as 
development continues. Mild models of perinatal injury have 
recently shown altered neuronal arborization in the sheep 
subplate (McClendon et  al., 2017) and cortex (Dean et  al., 
2013), though these were not specific to interneurons. These 
changes in arborization are generally interpreted as a delayed 
maturation, consistent with diffusion tensor imaging data showing 
altered diffusion characteristics in the cortex of preterm infants 
(Ball et  al., 2013). These most likely reflect reduced cortical 
complexity and contribute to a delay in  local connection 
formation (Batalle et  al., 2019), which will have downstream 
effects on subsequent brain development. The mechanism of 
delayed maturation is, as yet, unclear but could be  due to 
delayed interneuron migration to the correct position within 
the cortex (as discussed above). Alternatively, this may be  due 
to intrinsic changes that have occurred within the cells as a 
result of the injury or due to a wider disruption of the network 
and integration of neurons within it. More work is required 
to elucidate this process.
Perineuronal nets are a dynamic structure of extracellular 
matrix proteins that develop around a subpopulation of neurons 
in the brain. Parvalbumin interneurons are one of the cell types 
most commonly associated with perineuronal nets, and it has 
been suggested that these nets modulate the connections between 
cells and the plasticity to form new connections (Shen, 2018). 
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The presence of perineuronal nets around parvalbumin 
interneurons regulates Otx2 levels and critical periods of synaptic 
plasticity between these interneurons and their local networks 
(Beurdeley et  al., 2012). It is unclear in many reports of 
parvalbumin neuronal loss in clinical cases or animal models 
of injury/neurodevelopmental disorders whether the deficit is 
actually in the number of parvalbumin interneurons or in the 
expression of the parvalbumin protein within the neurons. In 
a SHANK3 knockout model of ASD, a significant loss of 
parvalbumin staining was observed in the cortex, but no disruption 
in the perineuronal nets, implying the presence of “parvalbumin-
neurons” but not of the parvalbumin protein (Filice et al., 2016). 
This phenotype in both SHANK3 and parvalbumin knockout 
mice suggests that loss of parvalbumin protein is associated 
with increased inhibition, whereas loss of the parvalbumin 
interneurons as a whole is associated with decreased inhibition 
(Wohr et  al., 2015; Filice et  al., 2016).
It should be  noted that a number of models of hypoxic-
ischemic perinatal injury have also shown changes in parvalbumin 
interneurons and, in some cases, their perineuronal nets. In 
the recent study by Fowke et  al. (2018), a substantial loss of 
interneurons was observed in the cortex, and there was an 
associated disruption of the perineuronal nets within 7  days 
of the injury, particularly in layer 6 of the cortex. Loss of 
calbindin and parvalbumin immunopositive neurons from the 
striatum has also been reported after perinatal asphyxia (Van 
de Berg et  al., 2003). However, as mentioned above, due to 
the much greater severity of this model of brain injury, compared 
with the inflammation-injury model used here, the mechanism 
of damage is likely to be  quite different. In the context of 
severe damage, it is unclear how much the interneuron damage 
alone contributes to the neuropathology and behavioral deficits 
observed in cases of human hypoxic-ischemic encephalopathy.
Early changes in calretinin-positive interneurons were also 
seen in this study, both in human and mouse tissue; however, 
in mouse, they did not persist after the initial injury period. 
Calretinin-positive neurons are present in the cortex from as 
early as 12  weeks of gestation in the human brain (Al-Jaberi 
et  al., 2015), possibly explaining their early response to injury. 
A reduction in calretinin-positive neurons was also observed 
in the visual cortex (but not other cortical regions) in a preterm 
baboon exposed to ventilator support (Verney et  al., 2010) 
but not in the caudate following prenatal cerebral ischemia 
in sheep (McClendon et  al., 2014). However, it has recently 
been shown that there is a significant decrease in size and 
number of calretinin-positive neurons in the caudate nucleus 
in the brains of autistic patients (Adorjan et  al., 2017). A 
previous study of adult males with autism also showed a 
decrease in calretinin-positive interneurons specifically localized 
in the dentate gyrus of the hippocampus and more widespread 
changes in parvalbumin-positive interneuron numbers (Lawrence 
et  al., 2010). Of note, Canetta et  al. (2016) clearly show no 
change in calretinin, or somatostatin, interneurons in their 
model of maternal immune activation-induced brain injury. 
This suggests that calretinin and parvalbumin injury may occur 
via different mechanisms, or that early, mild changes in calretinin 
interneurons are normalized as development progresses.
The altered frequency of synaptic boutons on the dendrites 
of Golgi stained neurons in the cortex was an interesting 
finding. Favuzzi et  al. (2017) have shown that altering the 
integrity of perineuronal nets by the deletion of one component, 
in this case brevican, alters the electrophysical properties of 
interneurons, and subsequently the number of synapses of 
parvalbumin interneurons onto pyramidal neurons. While in 
the present study, there was not a significant loss of perineuronal 
nets at P40, the time when this altered synaptic distribution 
was observed, there was a small but significant decrease in 
the number of cells positive for both parvalbumin and 
perineuronal nets. This may suggest an on-going reduction in 
inhibitory control in the cortex and a related change in the 
pyramidal neuron function. Electrophysiological studies will 
need to be  performed to confirm if this is the case. However, 
it is important to note that long-term behavioral changes have 
been observed in this mouse model (Favrais et al., 2011) where 
animals treated with IL-1β from P1 to P5 fail to recognize 
novel or displaced objects in memory tests. Brevican deletion 
in the adult also showed impaired working and short-term 
memory (Favuzzi et  al., 2017) supporting the assumption that 
the reduction in parvalbumin interneurons and perineuronal 
nets observed in this study may contribute to a disordered 
brain function.
In conclusion, this study provides clinically important 
information on the effects of preterm birth to decrease 
parvalbumin neurons and their perineuronal nets, disrupt the 
excitatory-inhibitory cell balance, and reduce spine density in 
the cortex. Altogether, these suggest that a decrease in cortical 
inhibition may result from preterm birth and its associated 
exposures to inflammatory injuries, though the potential 
contribution of other factors in this complex clinical situation 
cannot be ruled out. The pathology can be consistently recognized 
from P10  in the mouse, approximately equivalent to term in 
humans. This suggests that it may be possible for pharmacological 
tools that modulate cortical excitability to correct the abnormal 
developmental trajectory of the brain. This would open 
therapeutic avenues for reducing the long-term burden of 
neurodevelopmental sequelae occurring in many millions of 
infants every year due to brain injury associated with 
preterm birth.
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